Incidence and determinants of sub-optimal drug treatment in chronic heart failure: a single center pilot survey.
Anno:
2024
Background: the latest European Society of Cardiology guidelines on heart failure (HF) recommend a pharmacological treatment including 4 drugs (ARNI or ACE-inhibitor, beta-blocker, SGLT-2 inhibitor and MRA), with a class I indication in patients with HFrEF. However, the implementation of the 4 pillars approach is still largely insufficient in…